{"id":280,"date":"2024-05-10T20:22:58","date_gmt":"2024-05-10T20:22:58","guid":{"rendered":"https:\/\/www.libertymanagement.us\/fda-support\/?p=280"},"modified":"2024-05-10T20:22:58","modified_gmt":"2024-05-10T20:22:58","slug":"drug-master-file","status":"publish","type":"post","link":"https:\/\/www.libertymanagement.us\/fda-support\/2024\/05\/10\/drug-master-file\/","title":{"rendered":"Drug Master File"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">A <a href=\"https:\/\/www.fdahelp.us\/drug-master-files.html\">Drug Master File or (DMF)<\/a> is a confidential submission to the US FDA that provides detailed information about facilities, processes, or components used in the manufacturing, processing, packaging, and storing of <a href=\"https:\/\/www.fdahelp.us\/drugs.html\">drugs<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The DMF is submitted by a manufacturer, supplier, or\ndeveloper of an API (active pharmaceutical ingredient), excipient, or packaging\nmaterial, and it allows them to provide information to the regulatory authority\nwithout disclosing the information to their customers or competitors.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A DMF is referenced in a drug application, such as an ANDA\nor NDA Application, by the applicant who intends to use the information\ncontained in the DMF to support their own application. The regulatory authority\ncan then review the information in the DMF as part of the evaluation of the\ndrug application.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The purpose of a DMF is to provide information to the\nregulatory authority, without disclosing proprietary information to the public,\nto support the regulatory review process of a drug product. This allows the\nregulatory authority to evaluate the quality, safety, and efficacy of the drug\nproduct without needing to disclose confidential information to third parties.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DMF submissions are not mandatory and DMF applications are\nneither approved nor rejected by FDA. DMFs are subject to strict\nconfidentiality requirements and are not publicly available. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DMF holders are required to notify FDA of any changes in the\ncontents of DMF, authorized parties, transfer of ownership etc. An annual\nreport must be submitted every year listing all changes since the previous\nannual report. Foreign DMF holders are required to appoint a <a href=\"https:\/\/www.fdahelp.us\/fda-registration-agent.html\">US Agent<\/a> in their\nsubmissions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Types of Drug Master Files:<\/p>\n\n\n\n<ol class=\"wp-block-list\"><li>Type I: Manufacturing Site, Facilities,\nOperating Procedures, and Personnel<\/li><li>Type II: Drug Substance, Drug Substance\nIntermediate, and Material Used in Their Preparation, or Drug Product<\/li><li>Type III: Packaging Material<\/li><li>Type IV: Excipient, Colorant, Flavor, Essence,\nor Material Used in Their Preparation<\/li><li>Type V: FDA Accepted Reference Information<\/li><\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.fdahelp.us\/\">Liberty Management Group\nLtd.<\/a> can help you with DMF original and annual report submissions &amp; US\nAgent service. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Namrata <\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Regulatory Consultant<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>support@libertymanagement.us<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/www.fdahelp.us\">www.fdahelp.us<\/a><em><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Drug Master File or (DMF) is a confidential submission to the US FDA that provides detailed information about facilities, processes, or components used in the manufacturing, processing, packaging, and storing of drugs. The DMF is submitted by a manufacturer, supplier, or developer of an API (active pharmaceutical ingredient), excipient, or packaging material, and it &hellip; <a href=\"https:\/\/www.libertymanagement.us\/fda-support\/2024\/05\/10\/drug-master-file\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Drug Master File&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[38],"tags":[72,92,73,37],"class_list":["post-280","post","type-post","status-publish","format-standard","hentry","category-us-fda-registration","tag-dmf","tag-drug","tag-drug-master-file","tag-us-agent"],"_links":{"self":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/280","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/comments?post=280"}],"version-history":[{"count":1,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/280\/revisions"}],"predecessor-version":[{"id":281,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/280\/revisions\/281"}],"wp:attachment":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/media?parent=280"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/categories?post=280"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/tags?post=280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}